Acquisition Reinforces Thermo Fisher's Extensive Portfolio of
Laboratory Centrifuge Rotors
WALTHAM, Mass.--(BUSINESS WIRE)--July 25, 2008--Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science,
today announced that it has acquired FIBERLite Centrifuge, Inc., of
Santa Clara, California. FIBERLite is the world's foremost supplier of
carbon fiber centrifuge rotors, a strong and lightweight alternative
that provides customers with a number of advantages over traditional
metal rotors, including performance, safety, productivity and
durability.
"We have been offering FIBERLite rotors as an alternative to
aluminum and titanium rotors in our Thermo Scientific laboratory
centrifuges for several years, and we have seen customer demand for
the technology continue to grow," said Marijn E. Dekkers, president
and chief executive officer of Thermo Fisher Scientific. "FIBERLite's
patented carbon fiber rotors, along with its strong patent portfolio,
will enhance our centrifugation offering and bring additional R&D
capabilities."
Thermo Fisher Scientific designs, develops and manufactures a
comprehensive range of high-quality centrifuges, rotors and
accessories under the Thermo Scientific brand. Centrifuge models range
from bench-top microcentrifuges to floor-standing ultracentrifuges,
allowing Thermo Fisher Scientific to support all laboratory
applications, from routine sample preparation to cutting-edge cell and
molecular biology research techniques.
FIBERLite, which had revenues of approximately $7 million in 2007,
will be integrated into Thermo Fisher's Laboratory Products and
Services Segment.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With annual revenues of $10 billion, we have more
than 30,000 employees and serve over 350,000 customers within
pharmaceutical and biotech companies, hospitals and clinical
diagnostic labs, universities, research institutions and government
agencies, as well as environmental and industrial process control
settings. Serving customers through two premier brands, Thermo
Scientific and Fisher Scientific, we help solve analytical challenges
from routine testing to complex research and discovery. Thermo
Scientific offers customers a complete range of high-end analytical
instruments as well as laboratory equipment, software, services,
consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of
laboratory equipment, chemicals, supplies and services used in
healthcare, scientific research, safety and education. Together, we
offer the most convenient purchasing options to customers and
continuously advance our technologies to accelerate the pace of
scientific discovery, enhance value for customers and fuel growth for
shareholders and employees alike. Visit www.thermofisher.com.
The following constitutes a "Safe Harbor" statement under the
Private Securities Litigation Reform Act of 1995: This press release
contains forward-looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to
differ materially from those indicated by such forward-looking
statements are set forth in the company's Quarterly Report on Form
10-Q for the quarter ended March 29, 2008, under the caption "Risk
Factors," which is on file with the Securities and Exchange Commission
(SEC) and available in the "Investors" section of our Website under
the heading "SEC Filings." Important factors that could cause actual
results to differ materially from those indicated by forward-looking
statements include risks and uncertainties relating to: the risk that
the legacy businesses of Thermo Electron Corporation ("Thermo") and
Fisher Scientific International Inc. ("Fisher") will not be integrated
successfully; the risk that the cost savings and any other synergies
from the merger of Thermo and Fisher may not be fully realized or may
take longer to realize than expected; competition and its effect on
pricing, spending, third-party relationships and revenues; the need to
develop new products and adapt to significant technological change;
implementation of strategies for improving internal growth; use and
protection of intellectual property; dependence on customers' capital
spending policies and government funding policies; realization of
potential future savings from new productivity initiatives; general
worldwide economic conditions and related uncertainties; the effect of
changes in governmental regulations; the effect of exchange rate
fluctuations on international operations; the effect of laws and
regulations governing government contracts; the effect of competing
with certain of our customers and suppliers; and the effect of rapid
changes in the healthcare industry. While we may elect to update
forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if our estimates
change and, therefore, you should not rely on these forward-looking
statements as representing our views as of any date subsequent to
today.
CONTACT: Thermo Fisher Scientific Inc.
Media Contact Information:
Karen Kirkwood, 781-622-1306
karen.kirkwood@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com
www.thermofisher.com
SOURCE: Thermo Fisher Scientific Inc.
